Placebo News and Research

RSS

Transplanted stem cells hoped to be able to regenerate damaged heart muscle in first heart attack victims

Rush cardiologists are hoping that transplanted stem cells can regenerate damaged heart muscle in those who experience a first heart attack. The study involves an intravenous infusion of adult mesenchymal stem cells from healthy donor bone marrow that might possibly reverse damage to heart tissue.

28 Apr 2006

HRT can reduce heart attacks by about one-third in women under age 60

For the last few years, women have heard conflicting reports about the risks and benefits of hormone replacement therapy (HRT). A new study that analyzes many trials together concludes that HRT can reduce heart attacks by about one-third in women under age 60 but has mixed results for older women.

23 Apr 2006

Hypnotherapy relieves chest pain not linked to heart disease

According to a small study in the UK, hypnotherapy was helpful in relieving the angina-like chest pain experienced by some people which is not caused by heart disease.

23 Apr 2006

Corticosteroids do not improve survival in patients with late-stage acute respiratory distress syndrome

The study is the first multi-center randomized clinical trial to evaluate the effects of moderate doses of steroids in ARDS patients when treatment is started 7 days or more after the onset of the condition.

20 Apr 2006

New orthostatic hypotension treatment reduces symptoms without causing high blood pressure

A drug traditionally used to treat myasthenia gravis shows potential benefit for reducing symptoms of orthostatic hypotension without raising blood pressure when people lie down, according to results of a double-blind, controlled clinical trial.

19 Apr 2006

Herbal medicines may be as effective as pain medication for short-term low back pain

The herbal preparations devil's claw, white willow bark and cayenne plasters may be as effective as pain medication for short-term low back pain and are better than placebo, a new systematic review of studies has found.

18 Apr 2006

Researchers develop model to assess prostate cancer risk

Researchers have developed a model to predict prostate cancer for men who undergo a prostate biopsy. The details of the risk calculator appear in the Journal of the National Cancer Institute.

18 Apr 2006

First gene therapy human trial in the United States for a form of muscular dystrophy under way

The clinical trial for Duchenne muscular dystrophy (DMD) tests the safety and effectiveness of a therapy that was developed over two decades by scientists at the University of North Carolina Chapel Hill's School of Medicine and the University of Pittsburgh.

16 Apr 2006

Telithromycin antibiotic may help reduce some symptoms of a bad asthma attack

The researchers however believe the positive effects of the drug may be as a result of its impact on two bacteria - Chlamydophila pneumoniae and Mycoplasma pneumoniae - found present in 61% of patients in the study.

13 Apr 2006

Antibiotic telithromycin is effective at treating acute asthma attacks

Researchers have demonstrated that an antibiotic is effective at treating acute asthma attacks, potentially providing a new way to help asthma sufferers.

13 Apr 2006

Trial of low-dose Isotretinoin for prevention of second primary tumors in head and neck cancer patients

Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.

13 Apr 2006

No evidence that taking estrogen alone increases the risk of breast cancer in postmenopausal women

The findings come three years after a related WHI study found that a different type of hormone therapy - which combined estrogen and progestin - did result in a higher risk of breast cancer among postmenopausal women.

13 Apr 2006

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

The results contrast with the previously reported WHI Estrogen plus Progestin Trial, which found an increase in breast cancer over about 5 years among those taking combined hormone therapy.

11 Apr 2006

Mount Sinai launches CombiRx trial to treat relapsing-remitting Multiple Sclerosis

Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis.

11 Apr 2006

Estrogen therapy increases the risk of blood clots in some women

According to new research postmenopausal women on estrogen therapy who have undergone a hysterectomy have an elevated risk of developing a blood clots in veins.

11 Apr 2006

Losartan can prevent progression of Marfan syndrome

A commonly prescribed blood pressure medication may provide the first ray of hope in preventing potentially deadly complications of Marfan syndrome, a genetic disease that weakens the structural meshwork of blood vessels.

11 Apr 2006

Evaluation of an inactivated subunit H5N1 influenza virus vaccine in humans

Results from a clinical trial demonstrate that high doses of an experimental H5N1 avian influenza vaccine can induce immune responses in healthy adults.

11 Apr 2006

Estrogen therapy may increase the risk of venous thrombosis

Estrogen therapy may increase the risk of venous thrombosis, the formation of blood clots in the veins, among postmenopausal women who have had their uterus removed, according to a study in the April 10 issue of Archives of Internal Medicine.

11 Apr 2006

Peptide for myocardial infarction proves to be safe

FIBREX Medical has successfully completed a first dose in man study with its lead product, the anti-inflammatory peptide FX06.

6 Apr 2006

Cervical cancer vaccine gives women 4 years protection

Researchers say a vaccine that protects women against a virus that causes cervical cancer is effective for more than four years.

6 Apr 2006

Placebo News and Research

Transplanted stem cells hoped to be able to regenerate damaged heart muscle in first heart attack victims

HRT can reduce heart attacks by about one-third in women under age 60

Hypnotherapy relieves chest pain not linked to heart disease

Corticosteroids do not improve survival in patients with late-stage acute respiratory distress syndrome

New orthostatic hypotension treatment reduces symptoms without causing high blood pressure

Herbal medicines may be as effective as pain medication for short-term low back pain

Researchers develop model to assess prostate cancer risk

First gene therapy human trial in the United States for a form of muscular dystrophy under way

Telithromycin antibiotic may help reduce some symptoms of a bad asthma attack

Antibiotic telithromycin is effective at treating acute asthma attacks

Trial of low-dose Isotretinoin for prevention of second primary tumors in head and neck cancer patients

No evidence that taking estrogen alone increases the risk of breast cancer in postmenopausal women

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

Mount Sinai launches CombiRx trial to treat relapsing-remitting Multiple Sclerosis

Estrogen therapy increases the risk of blood clots in some women

Losartan can prevent progression of Marfan syndrome

Evaluation of an inactivated subunit H5N1 influenza virus vaccine in humans

Estrogen therapy may increase the risk of venous thrombosis

Peptide for myocardial infarction proves to be safe

Cervical cancer vaccine gives women 4 years protection

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News